NovaScan, a clinical stage oncology company based in Chicago, announced that it has started a human GI clinical trial for its nsCanary™ device at Texas International Endoscopy Center (TIEC), led by Principal Investigator Isaac Raijman MD. This trial will include 200 patients across several clinical areas, including upper and lower gastrointestinal lumen, pancreas and biliary tract. It is anticipated that the trial will collect the data by the Spring of 2023.
No Results Found
Sorry, the page you asked for could not be found.
It could be that the url is incorrect or is no longer available. Below are a few of our most recent articles from our blog. You can also refer to one of the links in our main menu at the top and bottom of this page.
read more
Abstract on FrostBite™ EUS-Compatible Cryocatheter Accepted for Presentation at the American College of Gastroenterology 2022 Annual Meeting
GI Cryo, Inc., a preclinical medical device development spin-off company from CPSI Biotech, will be presenting on the development and evaluation of the novel FrostBite™ endoscopic ultrasound (EUS) cryocatheter at the annual meeting for the American College of Gastroentrology (ACG2022) this October.
NovaScan Invited for Poster Presentation at ACG Annual Meeting
NovaScan, a clinical stage oncology company based in Chicago, announced that it will be presenting a poster at ACG Annual Scientific Meeting, to be held from October 21-26th at the Charlotte Convention Center in Charlotte NC.